Immunologic mapping of glycomes: Implications for cancer diagnosis and therapy

Frontiers in Bioscience - Scholar

Volumn 3 S, Issue 4, 2011, Pages 1520-1532

  Zhou, Dapeng ^a   Levery, Steven B ^b   Hsu, Fong Fu ^c   Wang, Peng G ^d   Teneberg, Susann ^e   Almeida, Igor C ^f   Li, Yunsen ^g   Xu, Huaxi ^h   Wang, Lai Xi ⁱ   Xia, Chengfeng ^j   Ibrahim, Nuhad K ^a   Michael, Katja ^f  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Diabetes   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f UNIVERSITY OF TEXAS AT EL PASO   (United States)

^g SOOCHOW UNIVERSITY   (China)

^h JIANGSU UNIVERSITY   (China)

ⁱ UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^j KUNMING INSTITUTE OF BOTANY   (China)

more..

Author keywords

Cancer; Glycomics; Immunopathogenesis; Immunotherapy; Mass spectrometry; Review

Indexed keywords

B LYMPHOCYTE RECEPTOR; BIOLOGICAL MARKER; CA 125 ANTIGEN; CA 15.3 ANTIGEN; CA 2.29 ANTIGEN; CANCER VACCINE; EPITOPE; GALECTIN; GANGLIOSIDE; GANGLIOSIDE GD2; GANGLIOSIDE GD2 ANTIBODY; GANGLIOSIDE GD3; GANGLIOSIDE GM2; GBH ANTIGEN; GLYCAN; GLYCOLIPID; GLYCOME; GLYCOPEPTIDE; GLYCOPROTEIN; GLYCOSPHINGOLIPID; GLYCOSYLTRANSFERASE; LECTIN; MONOCLONAL ANTIBODY; MUCIN 1 ANTIBODY; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN; T LYMPHOCYTE RECEPTOR; TN ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG; GLYCOCONJUGATE; LYMPHOCYTE ANTIGEN RECEPTOR; MEMBRANE ANTIGEN; POLYSACCHARIDE; SIALIC ACID BINDING IG LIKE LECTIN; SIALIC ACID BINDING IG-LIKE LECTIN;

ADAPTIVE IMMUNITY; AFFINITY CHROMATOGRAPHY; ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE; BREAST CANCER; CANCER DIAGNOSIS; CANCER IMMUNOTHERAPY; CARBOHYDRATE SYNTHESIS; DENDRITIC CELL; ELECTROSPRAY MASS SPECTROMETRY; EPITOPE MAPPING; GEL PERMEATION CHROMATOGRAPHY; GLYCOBIOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROPHILIC INTERACTION CHROMATOGRAPHY; HYDROPHOBIC INTERACTION CHROMATOGRAPHY; IMMUNOLOGIC MAPPING; IMMUNOLOGICAL PROCEDURES; INNATE IMMUNITY; ION TRAP MASS SPECTROMETRY; LIPIDOMICS; MACROPHAGE; MALIGNANT NEOPLASTIC DISEASE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MELANOMA; NATURAL KILLER T CELL; NEUROBLASTOMA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRE T LYMPHOCYTE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; T LYMPHOCYTE; TANDEM MASS SPECTROMETRY; X RAY CRYSTALLOGRAPHY; IMMUNOLOGY; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; NEOPLASM; REVIEW;

ADAPTIVE IMMUNITY; ANTIGENS, SURFACE; EPITOPES; GALECTINS; GLYCOCONJUGATES; GLYCOMICS; HUMANS; LECTINS; LECTINS, C-TYPE; MASS SPECTROMETRY; NEOPLASMS; POLYSACCHARIDES; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION;

EID: 80053105581     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/s242     Document Type: Article

References (77)

1. Matzinger P: The danger model: a renewed sense of self. Science 296(5566), 301-5 (2002)
2. Medzhitov R, Janeway CA Jr: Decoding the patterns of self and nonself by the innate immune system. Science 296(5566):298-300 (2002)
3. Mellman I, Turley SJ, Steinman RM: Antigen processing for amateurs and professionals. Trends Cell Biol 8(6):231-7 (1998)
4. Carpenter S, O'Neill LA: Recent insights into the structure of Toll-like receptors and post-translational modifications of their associated signalling proteins. Biochem J 422(1 ):1-10 (2009)
5. Rudensky AY: Endogenous peptides associated with MHC class II and selection of CD4 T cells. Semin Immunol 7(6):399-409 (1995)
6. Joyce S, Nathenson SG: Methods to study peptides associated with MHC class I molecules. Curr Opin Immunol 6(1):24-31 (1994)
7. Erratum in: Curr Opin Immunol 6(2):334 (1994)
8. Germain RN: Ligand-dependent regulation of T cell development and activation. Immunol Res 27(2-3):277-86 (2003)
9. Bendelac A: Nondeletional pathways for the development of autoreactive thymocytes. Nat Immunol 5(6):557-8 (2004)
10. Shui W, Petzold CJ, Redding A, Liu J, Pitcher A, Sheu L, Hsieh TY, Keasling JD, Bertozzi CR: Organelle membrane proteomics reveals differential influence of mycobacterial lipoglycans on macrophage phagosome maturation and autophagosome accumulation. J Proteome Res 10(1):339-48 (2011)
11. Cambi A, Figdor CG: Levels of complexity in pathogen recognition by C-type lectins. Curr Opin Immunol 17(4):345-51 (2005)
12. van Kooyk Y: C-type lectins on dendritic cells: key modulators for the induction of immune responses. Biochem Soc Trans 36(Pt 6):1478-81 (2008)
13. O'Reilly MK, Paulson JC: Siglecs as targets for therapy in immune-cell-mediated disease. Trends Pharmacol Sci 30(5):240-8 (2009)
14. Bochner BS, Alvarez RA, Mehta P, Bovin NV, Blixt O, White JR, Schnaar RL: Glycan array screening reveals a candidate ligand for Siglec-8. Sialoside analogue arrays for rapid identification of high affinity siglec ligands. J Biol Chem 280(6):4307-12 (2005)
15. Blixt O, Han S, Liao L, Zeng Y, Hoffmann J, Futakawa S, Paulson JC: Sialoside analogue arrays for rapid identification of high affinity siglec ligands. J Am Chem Soc 130(21):6680-1 (2008)
16. Barondes SH, Castronovo V, Cooper DN, Cummings RD, Drickamer K, Feizi T, Gitt MA, Hirabayashi J, Hughes C, Kasai K, et al: Galectins: a family of animal beta-galactoside-binding lectins. Cell 76(4):597-8 (1994)
17. Cerliani JP, Stowell SR, Mascanfroni ID, Arthur CM, Cummings RD, Rabinovich GA: Expanding the universe of cytokines and pattern recognition receptors: Galectins and glycans in innate immunity. J Clin Immunol [Epub ahead of print] (2010)
18. Dam TK, Brewer CF: Lectins as pattern recognition molecules: the effects of epitope density in innate immunity. Glycobiology 20(3):270-9 (2010)
19. Vasta GR: Roles of galectins in infection. Nat Rev Microbiol 7(6):424-38 (2009)
20. Dhirapong A, Lleo A, Leung P, Gershwin ME, Liu FT: The immunological potential of galectin-1 and -3. Autoimmun Rev 8(5):360-3 (2009)
21. Kurmyshkina O, Rapoport E, Moiseeva E, Korchagina E, Ovchinnikova T, Pazynina G, Belyanchikov I, Bovin N: Glycoprobes as a tool for the study of lectins expressed on tumor cells. Acta Histochem 112(2):118-26 (2010)
22. Zhang Y, Campbell C, Li Q, Gildersleeve JC: Multidimensional glycan arrays for enhanced antibody profiling. Mol Biosyst 6(9):1583-91.
23. Macher BA, Galili U: The Galalpha1,3Galbeta1,4GlcNAc-R (alpha-Gal) epitope: a carbohydrate of unique evolution and clinical relevance. Biochim Biophys Acta 1780(2):75-88 (2008)
24. Schietinger A, Philip M, Yoshida BA, Azadi P, Liu H, Meredith SC, Schreiber H: A mutant chaperone converts a wild-type protein into a tumor-specific antigen. Science 314(5797):304-8 (2006)
25. Zhou D, Levery SB: Response to Milland et al.: Carbohydrate residues downstream of the terminal Galalpha(1,3)Gal epitope modulate the specificity of xenoreactive antibodies. Immunol Cell Biol 86(8):631-2; authorreply 633-4 (2008)
26. Milland J, Christiansen D, Lazarus BD, Taylor SG, Xing PX, Sandrin MS: The molecular basis for galalpha(1,3)gal expression in animals with a deletion of the alpha1, 3galactosyltransferase gene. J Immunol 176(4):2448-54 (2006)
27. Harding CV, Kihlberg J, Elofsson M, Magnusson G, Unanue ER: Glycopeptides bind MHC molecules and elicit specific T cell responses. J Immunol 151(5):2419-25 (1993)
28. Cobb BA, Kasper DL: Coming of age: carbohydrates and immunity. Eur J Immunol 2005 Feb;35(2):352-6 (2005)
29. Taniguchi M, Nakayama T: Recognition and function of Valpha14 NKT cells. Semin Immunol 12(6):543-50 (2000)
30. Mattner J, Debord KL, Ismail N, Goff RD, Cantu C 3rd, Zhou D, Saint -Mezard P, Wang V, Gao Y, Yin N, Hoebe K, Schneewind O, Walker D, Beutler B, Teyton L, Savage PB, Bendelac A: Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434(7032):525-9 (2005)
31. Kinjo Y, Wu D, Kim G, Xing GW, Poles MA, Ho DD, Tsuji M, Kawahara K, Wong CH, Kronenberg M: Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434(7032):520-5 (2005)
32. Sriram V, Du W, Gervay-Hague J, Brutkiewicz RR: Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells. Eur J Immunol 35(6):1692-701 (2005)
33. Mattner J, Savage PB, Leung P, Oertelt SS, Wang V, Trivedi O, Scanlon ST, Pendem K, Teyton L, Hart J, Ridgway WM, Wicker LS, Gershwin ME, Bendelac A: Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe 3(5):304-15 (2008)
34. Shamshiev A, Gober HJ, D onda A, Mazorra Z, Mori L, De Libero G: Presentation of the same glycolipid by different CD1 molecules. J Exp Med 195(8):1013-21 (2002)
35. De Libero G, Mori L: Self glycosphingolipids: new antigens recognized by autoreactive T lymphocytes. News Physiol Sci 18:71-6 (2003)
36. Dias BR, Rodrigues EG, Nimrichter L, Nakayasu ES, Almeida IC, Travassos LR: Identification of iGb3 and iGb4 in melanoma B16F10-Nex2 cells and the iNKT cell-mediated antitumor effect of dendritic cells primed with iGb3. Mol Cancer 8:116 (2009)
37. Christiansen D, Milland J, Mouhtouris E, Vaughan H, Pellicci DG, McConville MJ, Godfrey DI, Sandrin MS: Humans lack iGb3 due to the absence of functional iGb3- synthase: implications for NKT cell development and transplantation. PLoS Biol 6(7):e172 (20 08)
38. Xia C, Schümann J, Emmanuel R, Zhang Y, Chen W, Zhang W, De Libero G, Wang PG: Modification of the ceramide moiety of isoglobotrihexosylceramide on its agonist activity in stimulation of invariant natural killer T cells. J Med Chem 50(15):3489-96 (2007)
39. Speak AO, Salio M, Neville DC, Fontaine J, Priestman DA, Platt N, Heare T, Butters TD, Dwek RA, Trottein F, Exley MA, Cerundolo V, Platt FM: Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals. Proc Natl Acad Sci U S A 104(14):5971-6 (2007)
40. Zhou D, Mattner J, Cantu C 3rd, Schrantz N, Yin N, Gao Y, Sagiv Y, Hudspeth K, Wu YP, Yamashita T, Teneberg S, Wang D, Proia RL, Levery SB, Savage PB, Teyton L, Bendelac A: Lysosomal glycosphingolipid recognition by NKT cells. Science 306( 5702):1786-9 (2004)
41. Behar SM, Porcelli SA: CD1-restricted T cells in host defense to infectious diseases. Curr Top Microbiol Immunol 314:215-50 (2007)
42. Gilleron M, Stenger S, Mazorra Z, Wittke F, Mariotti S, Böhmer G, Prandi J, Mori L, Puzo G, De Libero G: Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T cells during infection with Mycobacterium tuberculosis. J Exp Med 199(5):649-59 (2004)
43. Moody DB, Young DC, Cheng TY, Rosat JP, Roura-Mir C, O'Connor PB, Zajonc DM, Walz A, Miller MJ, Levery SB , Wilson IA, Costello CE, Brenner MB: T cell activation by lipopeptide antigens. Science 303(5657):527-31
44. Erratum in: Science 304(5668):211 (2004)
45. Felio K, Nguyen H, Dascher CC, Choi HJ , Li S, Zimmer MI, Colmone A, Moody DB, Brenner MB, Wang CR: CD1- restricted adaptive immune responses to Mycobacteria in human group 1 CD1 transgenic mice. J Exp Med 206(11):2497-509 (2009)
46. Kinjo Y, Tupin E, Wu D, Fujio M, Garcia-Navarro R, Benhnia MR, Zajonc DM, Ben-Menachem G, Ainge GD, Painter GF, Khurana A, Hoebe K, Behar SM, Beutler B, Wilson IA, Tsuji M, Sellati TJ, Wong CH, Kronenberg M: Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol 7(9):978-86 (2006)
47. Wang J, Li Y, Kinjo Y, Mac TT, Gibson D, Painter GF, Kronenberg M, Zajonc DM: Lipid binding orientation within CD1d affects recognition of Borrelia burgorferi antigens by NKT cells. Proc Natl Acad Sci U S A 107(4):1535-40 (2010)
48. Yamamoto F: Molecular genetics of ABO. Vox Sang 78 Suppl 2:91-1 (2000)
49. Levery SB: Glycosphingolipid structural analysis and glycosphingolipidomics. Methods Enzymol 405:300-69 (2005)
50. Haslam SM, Julien S, Burchell JM, Monk CR, Ceroni A, Garden OA, Dell A: Characterizing the glycome of the mammalian immune system. Immunol Cell Biol 86(7):564-73 (2008)
51. Kornfeld R, Kornfeld S: Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 54:631-64 (1985)
52. Zhou D: The immunological function of iGb3. Curr Protein Pept Sci 7(4):325-33 (2006)
53. Moody DB, Briken V, Cheng TY, Roura-Mir C, Guy MR, Geho DH, Tykocinski ML, Besra GS, Porcelli SA: Lipid length controls antigen entry into endosomal and nonendosomal pathways for CD1b presentation. Nat Immunol 3(5):435-42 (2002)
54. Darmoise A, Maschmeyer P, Winau F: The immunological functions of saposins. Adv Immunol 105:25-62 (2010)
55. Kang SJ, Cresswell P: Saposins facilitate CD1drestricted presentation of an exogenous lipid antigen to T cells. Nat Immunol 5(2):175-81 (2004)
56. L i Y, Thapa P, Hawke D, Kondo Y, Furukawa K, Furukawa K, Hsu FF, Adlercreutz D, Weadge J, Palcic MM, Wang PG, Levery SB, Zhou D: Immunologic glycosphingolipidomics and NKT cell development in mouse thymus. J Proteome Res 8(6):2740-51 (2009)
57. Ashline DJ, Lapadula AJ, Liu YH, Lin M, Grace M, Pramanik B, Reinhold VN: Carbohydrate structural isomers analyzed by sequential mass spectrometry. Anal Chem 79(10):3830-42 (2007)
58. Li Y, Zhou D, Xia C, Wang PG, Levery SB: Sensitive quantitation of isoglobotriaosylceramide in the presence of isobaric components using electrospray ionization-ion trap mass spectrometry. Glycobiology 18(2):166-76 (2008)
59. Li Y, Teneberg S, Thapa P, Bendelac A, Levery SB, Zhou D: Sensitive detection of isoglobo and globo series tetraglycosylceramides in human thymus by ion trap mass spectrometry. Glycobiology 18(2):158-65
60. Erratum in: Glycobiology 18(8):568 (2008)
61. Zhang S, Chelius D: Characterization of protein glycosylation using chip-based infusion nanoelectrospray linear ion trap tandem mass spectrometry. J Biomol Tech 15(2):120-33 (2004)
62. Sun B, Ranish JA, Utleg AG, White JT, Yan X, Lin B, Hood L: Shotgun glycopeptide capture approach coupled with mass spectrometry for comprehensive glycoproteomics. Mol Cell Proteomics 6(1):141-9 (2007)
63. Deguchi K, Ito H, Baba T , Hirabayashi A, Nakagawa H, Fumoto M, Hinou H, Nishimura S: Structural analysis of Oglycopeptides employing negative- and positive-ion multistage mass spectra obtained by collision-induced and electroncapture dissociations in linear ion trap time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 21(5):691-8 (2007)
64. Stalnaker SH, Hashmi S, Lim JM, Aoki K, Porterfield M, Gutierrez-Sanchez G, Wheeler J, Ervasti JM, Bergmann C, Tiemeyer M, Wells L: Site mapping and characterization of Oglycan structures on alpha-dystroglycan isolated from rabbit skeletal muscle. J Biol Chem 285(32):24882-91 (2010)
65. Nilsson J, Nilsson J, Larson G, Grahn A: Characterization of site-specific O-glycan structures within the mucin-like domain of alpha-dystroglycan from human skeletal muscle. Glycobiology 20(9):1160-9 (2010)
66. Wang Y, Wu SL, Hancock WS: Approaches to the study of N-linked glycoproteins in human plasma using lectin affinity chromatography and nano-HPLC coupled to electrospray linear ion trap - Fourier transform mass spectrometry. Glycobiology 16(6):514-23 (2006)
67. Wada Y, Tajiri M, Yoshida S: Hydrophilic affinity isolation and MALDI multiple-stage tandem mass spectrometry of glycopeptides for glycoproteomics. Anal Chem 76(22):6560-5 (2004)
68. Taguchi R, Houjou T, Nakanishi H, Yamazaki T, Ishida M, Imagawa M, Shimizu T: Focused lipidomics by tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 823(1):26-36 (2005)
69. Crul M, Mathôt RA, G iaccone G, Punt CA, Rosing H, Hillebrand MX, Ando Y, Nishi N, Tanaka H, Schellens JM, Beijnen JH: Population pharmacokinetics of the novel anticancer agent KRN7000. Cancer Chemother Pharmacol 49(4):287-93 (2002)
70. Holmberg LA, Sandmaier BM: Vaccination with Theratope (STn-KLH) as treatment for breast cancer. Expert Rev Vaccines 3(6):655-63 (2004)
71. Ragupathi G: Carbohydrate antigens as targets for active specific immunotherapy. Cancer Immunol Immunother 43(3):152-7 (1996)
72. Livingston P: Ganglioside vaccines with emphasis on GM2. Semin Oncol 25(6):636-45 (1998)
73. Zhu J, Wan Q, Lee D, Yang G, Spassova MK, Ouerfelli O, Ragupathi G, Damani P, Livingston PO, Danishefsky SJ: From synthesis to biologics: preclinical data on a chemistry derived anticancer vaccine. J Am Chem Soc 131(26):9298-303 (2009)
74. Vasan M, Rauvolfova J, Wolfert MA, Leoff C, Kannenberg EL, Quinn CP, Carlson RW, Boons GJ: Chemical synthesis and immunological properties of oligosaccharides derived from the vegetative cell wall of Bacillus anthracis. Chembiochem 9(11):1716-20 (2008)
75. Werz DB, Seeberger PH: Totalsynthesis of antigen bacillus anthracis tetrasaccharide - creation of an anthrax vaccine candidate. Angew Chem Int Ed Engl 44(39):6315-8 (2005)
76. Almeida IC, Covas DT, Soussumi LM, Travassos LR : A highly sensitive and specific chemiluminescent enzymelinked immunosorbent assay for diagnosis of active Trypanosoma cruzi infection. Transfusion 37(8):850-7 (1997)
77. Nelson BC, Roddy T, Araghi S, Wilkens D, Thomas JJ, Zhang K, Sung CC, Richards SM: Globotriaosylceramide isoform profiles in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 805(1):127-34 (2004)